Response According to Site of Metastases in Patients with Metastatic RCC (Renal Cell Carcinoma) During Treatment with Interferon Alpha in Combination with 5-Fluorouracil
We present our preliminary results. Of 30 patients with M1 renal cell carcinoma, 21 were included in our prospective controlled pilot study until March 14, 1992. These 21 patients were evaluated for efficacy in the treatment with recombinant interferon alfa-2b in combination with 5-fluorouracil (5-FU).
KeywordsRenal Cell Carcinoma Bone Metastasis Karnofsky Performance Status Soft Tissue Metastasis Interferon Alpha Therapy
Unable to display preview. Download preview PDF.